ENTITY
New Horizon Health

New Horizon Health (6606 HK)

58
Analysis
Health CareChina
New Horizon Health Limited operates cancer screening technology development business. The Company develops and sells colorectal cancer screening test products, gastric cancer screening test products, and other products. New Horizon Health markets its products throughout China.
more
Refresh
03 Jun 2021 11:09

HSI Index Rebalance Preview: Potential Inclusions in September

There could be 8 additions to the HSI at the September review to take the index members up to 66. Turnover will be less than 5% and there are a lot...

Logo
445 Views
Share
bullishYidu Tech Inc
18 May 2021 10:26

HSCI Index Rebalance and Stock Connect: Potential Changes in June and September

A look at the potential changes to the HSCI at the June & September reviews and stocks that could be included in/excluded from Stock Connect. These...

Logo
494 Views
Share
04 Mar 2021 09:54

New Horizon Health (6606.HK) - Still Has a Long Way to Go

The article analyzed the major concerns in China’s market of early screening (difficulty in BD, pricing, payment systems, etc.), which would...

Logo
272 Views
Share
bullishTencent
21 Feb 2021 10:22

ECM Weekly (21 February 2021) - Tencent Lock-Up Expiry, SciClone Pharma, Joinn Lab, Bairong, Betta

Aequitas Research puts out a weekly update on the deals that have been covered by the team recently along with updates for upcoming IPOs.

Share
19 Feb 2021 19:54

New Horizon Health IPO Trading Update: A Blockbuster IPO but It’s Time You Plan an Exit Strategy

New Horizon Health (NHH), the pioneer in China’s colorectal cancer screening market started trading on the Hong Stock Exchange on 18th February. T

Share
x